Diosmin
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Diosmin (diosmetin 7-O-rutinoside), a flavone glycoside of diosmetin, is manufactured from citrus fruit peels as a phlebotonic non-prescription dietary supplement used to aid treatment of hemorrhoids or chronic venous diseases, mainly of the legs.
Indications
Diosmin is primarily indicated in conditions like Hemorrhoids, Venous lymphatic insufficiency, and can also be given in adjunctive therapy as an alternative drug of choice in Leg ulcer.
Contraindications
Diosmin is contraindicated in conditions like Hypersensitivity to any component of product.
Side Effects
The symptomatic adverse reactions produced by Diosmin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, GI upset, Autonomic complaints.
Warnings
Diosmin should be used with caution in the patient of acute hemorrhoidal attack. The administration of this product does not preclude treatment for other anal conditions. The treatment should be short duration. If symptoms do not subside promptly, a proctological examination should be performed and the treatment should be reviewed.
High Risk Groups
Drug should not be given to Paediatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
450 mg (450 (450)) 12 hourly PO — As Required
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
Serum concentrations may be increased by coadministration of drugs metabolized by cytochrome P450 (CYP-450) 2E1 or 2C9, or by P-glycoprotein.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
1 active brand listed alphabetically.
DAFLON
ActiveSERVIER RESEARCH & PHARMACEUTICALS PAKISTAN (PVT) LTD.
DML: DAFLON
Tabs
1 additional record is present but flagged "Unverified / Legacy" and not listed.